Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ABBOTT INDIA LTD.

NSE : ABBOTINDIABSE : 500488ISIN CODE : INE358A01014Industry : Pharmaceuticals & DrugsHouse : Abbott India - MNC

BSE28078.8039.5 (+0.14 %)

PREV CLOSE ( ) 28039.30

OPEN PRICE ( ) 28000.00

BID PRICE (QTY) 28039.60 (1)

OFFER PRICE (QTY) 28078.85 (1)

VOLUME 223

TODAY'S LOW / HIGH ( )27910.00 28134.60

52 WK LOW / HIGH ( )25260.2 35921.55

NSE28055.0020 (+0.07 %)

PREV CLOSE( ) 28035.00

OPEN PRICE ( ) 28055.00

BID PRICE (QTY) 28055.00 (2)

OFFER PRICE (QTY) 28075.00 (28)

VOLUME 3530

TODAY'S LOW / HIGH( ) 27775.00 28195.00

52 WK LOW / HIGH ( )25325 37000

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 22-08 1944

Management Info

Munir Shaikh - Chairman Kartik Rajendran - Managing Director

Registered Office

Address Unit No. 3,Corporate Park,Sion Trombay Road,
Mumbai,
Maharashtra-400071

Phone 022-50461000 / 2000 / 67978888

Email webmasterindia@abbott.com / investorrelations.india@abbott.com

Website www.abbott.co.in

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

19Dec Abbott India informs about trading win
Abbott India has informed that in accordance with the provisions of the..

07Nov Abbott India informs about newspaper p
Pursuant to Regulation 47 of the Securities and Exchange Board of India..

01Aug Abbott India informs about disclosure
In the matter of compounding application filed by the Company with the R..

29Jul Abbott India informs about newspaper
Pursuant to Regulation 30 of the Securities and Exchange Board of India..

26Jun Abbott India informs about closure of
Abbott India has informed that, in accordance with the provisions of the..

Financials

Rs. in Millions

	QTR Sep 25	ANNUAL 25
Net Profit	4152.7	14144.4
Gross Profit	5459.3	18869.5
Operating Profit	5721.2	19701.8
Net Sales	17571.5	64091.5

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Fredun Pharma (BSE) 1750.00 (7.31%)	M.Cap ( in Cr)832.95
Alkem Laboratories (BSE) 5648.45 (1.56%)	M.Cap ( in Cr)67506.40
Ajanta Pharma (BSE) 2709.25 (3.31%)	M.Cap ( in Cr)33739.49
Sanofi India (BSE) 4125.00 (1.40%)	M.Cap ( in Cr)9482.28
NGL Fine-Chem (BSE) 1334.90 (4.34%)	M.Cap ( in Cr)824.70

Shareholding Pattern

	PROMOTERS	74.99%
	NON-INSTITUTION	15.75%
	MUTUAL FUNDS/UTI	7.78%
	FI/BANKS/INSURANCE	1.07%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Aditya Birla SL Pha...	6.92
Samco Flexi Cap Fun...	4.57
SBI MNC Fund-Reg(IDCW)	4.52
NJ ELSS Tax Saver S...	4.11
SBI Innovative Oppo...	4.06
LIC MF Healthcare F...	3.94
PGIM India Healthca...	3.79

Risk Disclosures on Derivatives

Smart Quotes

ABBOTT INDIA LTD.